Morocco's Drug Price Reform Faces Public Skepticism Despite Government Promises

Monday 13 January 2025 - 12:20

By: Dakir Madiha

Morocco's Drug Price Reform Faces Public Skepticism Despite Government Promises

The Moroccan government's efforts to reduce medication prices continue to spark controversy despite repeated announcements of price cuts. Health and Social Protection Minister Amine Tahraoui recently declared impending price reductions for 190 medications targeting chronic diseases, though this ambitious announcement has been met with public skepticism due to delayed implementation.

Official figures indicate that since 2021, prices have been reduced for more than 5,350 medications, including 169 recent reductions focusing on chronic disease treatments. However, as Minister Tahraoui acknowledged in Parliament, medication pricing remains a contentious issue.

The 2023 pricing reform, intended to ease citizens' financial burden, has faced significant challenges. Rising production costs and the expansion of Mandatory Health Insurance (AMO) have put additional pressure on insurance companies, which struggle to manage increasing expenses while maintaining affordable coverage.

The government's 2023-2027 national plan aims to overhaul medication production and distribution mechanisms, emphasizing generic alternatives and supporting local pharmaceutical manufacturing. However, these initiatives have yet to meet public expectations.

This controversy reflects broader challenges within Morocco's healthcare system. While medical coverage has improved—with insurance coverage rising from less than 75% in 2020 to 80% in 2024—significant hurdles remain. Approximately 8.5 million citizens still lack health insurance, with 5 million unregistered and 3.5 million registered but receiving no benefits. Insured individuals continue to pay about 50% of medical expenses out-of-pocket, far exceeding World Health Organization recommendations.

Financial imbalances plague the insurance system. While AMO-Tadamon, designed for vulnerable populations, maintains stability, other programs face concerning deficits. The self-employed workers' scheme, for instance, reports a 72% deficit, highlighting structural issues in contribution and benefit management.

Healthcare access inequality remains a critical concern. Private clinics, charging up to five times more than public facilities, consume a large portion of healthcare spending, exacerbating disparities in essential care access. Government promises to enhance public hospital infrastructure and accessibility have yet to offset the impact of prohibitive private clinic costs.

Despite numerous announced price reductions, medication costs continue to frustrate many Moroccans. Implementation delays and systemic healthcare weaknesses have fostered public distrust in the promised reforms.